Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
CTD_human |
Loss of NRF2 function exacerbates the pathophysiology of sickle cell disease in a transgenic mouse model.
|
29255069 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the beta-globin gene (HBB) cause beta-thalassaemia and sickle cell anaemia.
|
29853423 |
2018 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
Genetic variants at three quantitative trait loci (QTL) for fetal haemoglobin (HbF), BCL11A, HBS1L-MYB and the β-globin gene cluster, have attracted interest as potential targets of therapeutic strategies for HbF reactivation in sickle cell anaemia (SCA).
|
29879141 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Globally, sickle cell disease (SCD) is one of the commonest severe monogenic disorders, due to the inheritance of two abnormal haemoglobin (beta globin) genes.
|
30067867 |
2018 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors.
|
28689691 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is caused by a mutation of the β-globin gene (Ingram VM.
|
30067082 |
2018 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
Sickle cell anemia (SCA) and β -thalassemia major are well-recognized beta-globin gene disorders of red blood cells associated to mortality and morbidity included bone morbidities due to ineffective erythropoiesis and bone marrow expansion, which affect every part of the skeleton.
|
29447888 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is an inherited blood disorder caused by a single amino acid substitution in the β-globin chain of hemoglobin.
|
30198339 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is a group of inherited disorders caused by mutations in HBB, which encodes haemoglobin subunit β.
|
29542687 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell anemia (SCA) is an autosomal recessive disorder caused by mutation in the β-globin gene.
|
28823762 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is a monogenetic disorder caused by a mutation in the β-globin gene HBB leading to polymerization of red blood cells causing damage to cell membranes, increasing its rigidity and intravascular hemolysis.
|
29614633 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The primary β-globin gene mutation that causes sickle cell disease (SCD) has significant pathophysiological consequences that result in hemolytic events and the induction of the inflammatory processes that ultimately lead to vaso-occlusion.
|
29614637 |
2018 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
Sickle cell disease (SCD) is an inherited disease of the beta globin gene.
|
29157167 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is an inherited disorder caused by a variant (<i>rs</i>334) in the β-globin gene encoding hemoglobin.
|
29385701 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
β-hemoglobinopathies such as sickle cell disease (SCD) and β-thalassemia result from mutations in the adult HBB (β-globin) gene.
|
29610478 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This strategy of restoring functional HBB gene expression will be able to correct most types of HBB gene mutations in β-thal and SCD.
|
29164808 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the beta-globin gene (HBB) cause beta-thalassaemia and sickle cell anaemia.
|
29853423 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
|
29164808 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Beta-thalassemia (β-thalassemia) minor is characterized by a mutation in one of the two β-globin genes (HBB) that produce the β-globin chains in the hemoglobin molecule.
|
30395680 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Beta-thalassemia is a genetic disorder that is caused by variations in the beta-hemoglobin (HBB) gene.
|
29619482 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We now report genetic correction of the beta hemoglobin (HBB) gene in iPSCs derived from a patient with a double heterozygote for hemoglobin E and β-thalassemia (HbE/β-thalassemia), the most common thalassemia syndrome in Thailand and Southeast Asia.
|
29482624 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
With this view in mind, the study aimed to establish a high resolution melting (HRM) curve-based rapid and reliable mutation screening method targeting the mutational hot-spot of South Asian and Southeast Asian countries that encompasses exon-1 (c.1 - c.92), intron-1 (c.92 + 1 - c.92 + 130) and a portion of exon-2 (c.93 - c.217) of the HBB gene which harbors more than 95% of mutant alleles responsible for beta-thalassemia in Bangladesh.
|
29295702 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genotype-phenotype Correlation of β-Thalassemia in Croatian Patients: A Specific HBB Gene Mutations.
|
29240028 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle Cell Disease (SCD) is a painful, lifelong hemoglobinopathy inherited as a missense point mutation in the hemoglobin (Hb) beta-globin gene.
|
28378932 |
2017 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is one of the commonest severe monogenic disorders in the world, due to the inheritance of two abnormal haemoglobin (beta globin) genes.
|
28500860 |
2017 |